An expert discusses the vital role of comprehensive genomic profiling in personalizing treatment for non-small cell lung cancer, enhancing patient outcomes.
ONCOLOGY® Companion, Volume 39, Supplement 8
Recent advancements in multiple myeloma treatment highlight the efficacy of daratumumab combined with VRd, showcasing improved outcomes and tolerability.
Experts discuss evolving therapies for EGFR-mutated metastatic NSCLC, comparing combination regimens and their impact on patient outcomes.
Advertisement
Advertisement
Trending on CancerNetwork
1
3 Things You Should Know About TROP2 as a Therapeutic Target in Triple-Negative Breast Cancer
2
Considering Subsequent Treatment in NDMM After Teclistamab-Based Induction
3
IMNN-001/Chemo Displays TME Shift in Newly Diagnosed Ovarian Cancer
4
Universal Testing May Help Bolster Long Term Ovarian Cancer Survivorship
5
